Your browser doesn't support javascript.
loading
Interplay of sex hormones and long-term right ventricular adaptation in a Dutch PAH-cohort.
van Wezenbeek, Jessie; Groeneveldt, Joanne A; Llucià-Valldeperas, Aida; van der Bruggen, Cathelijne E; Jansen, Samara M A; Smits, A Josien; Smal, Rowan; van Leeuwen, Joost W; Remedios, Cris Dos; Keogh, Anne; Humbert, Marc; Dorfmüller, Peter; Mercier, Olaf; Guignabert, Christophe; Niessen, Hans W M; Handoko, M Louis; Marcus, J Tim; Meijboom, Lilian J; Oosterveer, Frank P T; Westerhof, Berend E; Heijboer, Annemieke C; Bogaard, Harm Jan; Vonk Noordegraaf, Anton; Goumans, Marie José; de Man, Frances S.
Afiliação
  • van Wezenbeek J; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Groeneveldt JA; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Llucià-Valldeperas A; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • van der Bruggen CE; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Jansen SMA; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Smits AJ; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Smal R; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • van Leeuwen JW; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Remedios CD; Victor Chang Cardiac Research Institute, Darlinghurst, Australia; University of Sydney, Sydney, Australia.
  • Keogh A; Heart Transplant Unit, St Vincent's Public Hospital, Sydney, Australia; University of NSW, Sydney, Australia.
  • Humbert M; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; Université Paris-Saclay, Hypertension pulmonaire: physiopathologie et innovation thérapeutique, Le Ple
  • Dorfmüller P; Assistance Publique - Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; Université Paris-Saclay, Hypertension pulmonaire: physiopathologie et innovation thérapeutique, Le Ple
  • Mercier O; INSERM UMR_S 999, Hypertension pulmonaire: physiopathologie et innovation thérapeutique, Le Plessis Robinson, France; Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Hôpital Marie Lannelongue, Le Plessis Robinson, France; Department of Thoracic and Vascular Surgery and He
  • Guignabert C; INSERM UMR_S 999, Hypertension pulmonaire: physiopathologie et innovation thérapeutique, Le Plessis Robinson, France; Université Paris-Saclay, Hypertension pulmonaire: physiopathologie et innovation thérapeutique, Le Plessis Robinson, France.
  • Niessen HWM; Department of Pathology, Amsterdam University Medical Centers, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
  • Handoko ML; Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
  • Marcus JT; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
  • Meijboom LJ; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
  • Oosterveer FPT; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Westerhof BE; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; University of Twente, Technical Medical Centre, Cardiovascular and Respiratory Physiology, Enschede, The Netherlands.
  • Heijboer AC; Endocrine Laboratory, Department of Clinical Chemistry, Amsterdam UMC, Vrije Universiteit Amsterdam and University of Amsterdam, Amsterdam Gastroenterology Endocrinology & Metabolism, Amsterdam, The Netherlands.
  • Bogaard HJ; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Vonk Noordegraaf A; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Goumans MJ; Department of Cell and Chemical Biology, Leiden UMC, Leiden, the Netherlands.
  • de Man FS; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. Electronic address: fs.deman@amsterdamumc.nl.
J Heart Lung Transplant ; 41(4): 445-457, 2022 04.
Article em En | MEDLINE | ID: mdl-35039146
BACKGROUND: To investigate the association between altered sex hormone expression and long-term right ventricular (RV) adaptation and progression of right heart failure in a Dutch cohort of Pulmonary Arterial Hypertension (PAH)-patients across a wide range of ages. METHODS: In this study we included 279 PAH-patients, of which 169 females and 110 males. From 59 patients and 21 controls we collected plasma samples for sex hormone analysis. Right heart catheterization (RHC) and/or cardiac magnetic resonance (CMR) imaging was performed at baseline. For longitudinal data analysis, we selected patients that underwent a RHC and/or CMR maximally 1.5 years prior to an event (death or transplantation, N = 49). RESULTS: Dehydroepiandrosterone-sulfate (DHEA-S) levels were reduced in male and female PAH-patients compared to controls, whereas androstenedione and testosterone were only reduced in female patients. Interestingly, low DHEA-S and high testosterone levels were correlated to worse RV function in male patients only. Subsequently, we analyzed prognosis and RV adaptation in females stratified by age. Females ≤45years had best prognosis in comparison to females ≥55years and males. No differences in RV function at baseline were observed, despite higher pressure-overload in females ≤45years. Longitudinal data demonstrated a clear distinction in RV adaptation. Although females ≤45years had an event at a later time point, RV function was more impaired at end-stage disease. CONCLUSIONS: Sex hormones are differently associated with RV function in male and female PAH-patients. DHEA-S appeared to be lower in male and female PAH-patients. Females ≤45years could persevere pressure-overload for a longer time, but had a more severe RV phenotype at end-stage disease.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Disfunção Ventricular Direita / Hipertensão Arterial Pulmonar Tipo de estudo: Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: J Heart Lung Transplant Assunto da revista: CARDIOLOGIA / TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Disfunção Ventricular Direita / Hipertensão Arterial Pulmonar Tipo de estudo: Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: J Heart Lung Transplant Assunto da revista: CARDIOLOGIA / TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda